In the News

Recent Coverage of HMS in the News
April 12, 2016

Paul Nguyen (Brigham and Women’s) led a study that suggests men who take hormone therapy for prostate cancer may have a higher risk of depression than patients who receive different treatment for these malignancies.

April 12, 2016

Patients diagnosed with chronic lymphocytic leukemia who have a specific gene mutation typically don't survive longer than three years, but a drug approved Monday, based on science out of Dana-Farber, could change that. Matthew Davids (Dana-Farber) is quoted. 

April 12, 2016

Marcia Angell (HMS) authored this opinion piece on the evolution of the New England Journal of Medicine's conflict-of-interest policies in medical research and the possible reasons for them.

April 11, 2016

The Drug Enforcement Agency announced last week that it is reviewing the possibility of reclassifying marijuana as a Schedule II drug, which would put it in the same category as Ritalin, Adderall and oxycodone. Kevin Hill (McLean) is quoted. 

April 11, 2016

David Bellinger (Boston Children's) co-authored this opinion piece offering a three-point program to end lead poisoning in the U.S. 

April 11, 2016

Allan Goroll (Mass General) authored this opinion piece about how the annual physical needs to be revitalized in the U.S. 

April 11, 2016

Dhruv Khullar (Mass General) authored this blog post about the importance of listening to patients' stories.

April 11, 2016

Isaac Kohane (HMS) participated in an interview about Daniel MacArthur's (Mass General) study on people who remain healthy even though they carry genetic variants known to cause severe Mendelian childhood diseases. 

Pages

Resources

Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.

 

Tell us about your awards
Share news of your achievements with the larger HMS community, click here.

 

Book Reviews
If you are a faculty member who has published a book recently, click here.